trusight Search Results


96
Illumina Inc human disease
Human Disease, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trusight/TruSight+One+Sequencing+Panel/10__3233_slash_jnd___189001-6817-10-17
Average 96 stars, based on 1 article reviews
human disease - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

95
Illumina Inc trusight oncology 500 kit
Trusight Oncology 500 Kit, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trusight/TruSight+Oncology+500+DNA%2FRNA+Kit/pm41062884-33-19-23
Average 95 stars, based on 1 article reviews
trusight oncology 500 kit - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

96
Illumina Inc trusight rna pan cancer
Trusight Rna Pan Cancer, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trusight/TruSight+RNA+Pan-Cancer+Panel+Set+A/pmc07705438-19259-19-22
Average 96 stars, based on 1 article reviews
trusight rna pan cancer - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

95
Illumina Inc rna library preparation
Rna Library Preparation, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trusight/TruSight+Tumor+170+Kit/10__1097_slash_corr__0000000000002901-113-3-13
Average 95 stars, based on 1 article reviews
rna library preparation - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

98
Illumina Inc trusight oncology 500
( A ) Next-generation sequencing by using Illumina <t>TSO500</t> identified EWSR1-CREM fusion in the tumor. Additional benign and uncertain mutations in ASXL1, PARP1, EPHAS, CCND3 were found. ( B ) Upon closer examination of the EWSR1-CREM fusion, we were able to determine ( C ) that this tumor originated from a fusion event involving exon 8 of the gene EWSR1 and exon 6 of the gene CREM.
Trusight Oncology 500, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trusight/TruSight+Oncology+500+ctDNA/pmc11051956-96-8-7
Average 98 stars, based on 1 article reviews
trusight oncology 500 - by Bioz Stars, 2026-10
98/100 stars
  Buy from Supplier

93
Illumina Inc trusight hla v2 sequencing panel kit
( A ) Next-generation sequencing by using Illumina <t>TSO500</t> identified EWSR1-CREM fusion in the tumor. Additional benign and uncertain mutations in ASXL1, PARP1, EPHAS, CCND3 were found. ( B ) Upon closer examination of the EWSR1-CREM fusion, we were able to determine ( C ) that this tumor originated from a fusion event involving exon 8 of the gene EWSR1 and exon 6 of the gene CREM.
Trusight Hla V2 Sequencing Panel Kit, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trusight/TruSight+HLA+v2+Sequencing+Panel/pm35748246-75-18-24
Average 93 stars, based on 1 article reviews
trusight hla v2 sequencing panel kit - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

95
Illumina Inc trusight oncology 500 dna kit
( A ) Next-generation sequencing by using Illumina <t>TSO500</t> identified EWSR1-CREM fusion in the tumor. Additional benign and uncertain mutations in ASXL1, PARP1, EPHAS, CCND3 were found. ( B ) Upon closer examination of the EWSR1-CREM fusion, we were able to determine ( C ) that this tumor originated from a fusion event involving exon 8 of the gene EWSR1 and exon 6 of the gene CREM.
Trusight Oncology 500 Dna Kit, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trusight/TruSight+Oncology+500+DNA+Kit/pm40076915-206-10-16
Average 95 stars, based on 1 article reviews
trusight oncology 500 dna kit - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

96
Illumina Inc trusight one expanded sequencing panel
( A ) Next-generation sequencing by using Illumina <t>TSO500</t> identified EWSR1-CREM fusion in the tumor. Additional benign and uncertain mutations in ASXL1, PARP1, EPHAS, CCND3 were found. ( B ) Upon closer examination of the EWSR1-CREM fusion, we were able to determine ( C ) that this tumor originated from a fusion event involving exon 8 of the gene EWSR1 and exon 6 of the gene CREM.
Trusight One Expanded Sequencing Panel, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trusight/TruSight+One+Expanded+Sequencing+Panel/pm35665751-20-8-20
Average 96 stars, based on 1 article reviews
trusight one expanded sequencing panel - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

96
Illumina Inc trusight rapid
Figure 4 Pipeline analysis for targeted NGS of multiple inherited cancer syndromes using the <t>TruSight</t> Cancer panel. In our analysis pipeline, .fastq files are used for alignment and variant calling in Isaac Enrichment, Burrows-Wheeler Aligner (BWA) Enrichment, and NextGENe software, and .vcf files are then imported to GeneticistAssistant for variant filtering. Supervised analysis of filtered variants will allow the identification of disease-associated variants and/or of pathogenic variants associated with cancer predisposing syndromes outside the clinical context (incidental finding), with both being supported (if needed) by visual inspection of .bam files in Golden Helix GenomeBrowse (GB). Variants called because <t>of</t> <t>sequencing</t> errors are discarded on visual inspection of .bam files in Golden Helix GB. 1000G, 1000 Genomes Project; ACMG, American College of Med- ical Genetics and Genomics; Alt.var.freq., percentage of reads with alter- native allele; CDS, coding sequence; EVS, Exome Variant Server; ExAC, Exome Aggregation Consortium; In-house freq., variant frequency among all of the samples in our in-house database; MAF, minor allele frequency.
Trusight Rapid, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trusight/TruSight+Rapid+Capture/pm28529006-32-12-16
Average 96 stars, based on 1 article reviews
trusight rapid - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

95
Illumina Inc trusight rna fusion panel
Figure 4 Pipeline analysis for targeted NGS of multiple inherited cancer syndromes using the <t>TruSight</t> Cancer panel. In our analysis pipeline, .fastq files are used for alignment and variant calling in Isaac Enrichment, Burrows-Wheeler Aligner (BWA) Enrichment, and NextGENe software, and .vcf files are then imported to GeneticistAssistant for variant filtering. Supervised analysis of filtered variants will allow the identification of disease-associated variants and/or of pathogenic variants associated with cancer predisposing syndromes outside the clinical context (incidental finding), with both being supported (if needed) by visual inspection of .bam files in Golden Helix GenomeBrowse (GB). Variants called because <t>of</t> <t>sequencing</t> errors are discarded on visual inspection of .bam files in Golden Helix GB. 1000G, 1000 Genomes Project; ACMG, American College of Med- ical Genetics and Genomics; Alt.var.freq., percentage of reads with alter- native allele; CDS, coding sequence; EVS, Exome Variant Server; ExAC, Exome Aggregation Consortium; In-house freq., variant frequency among all of the samples in our in-house database; MAF, minor allele frequency.
Trusight Rna Fusion Panel, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trusight/TruSight+RNA+Fusion+Panel+Set+A/pm37724942-33-92-91
Average 95 stars, based on 1 article reviews
trusight rna fusion panel - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

96
Illumina Inc trusight myeloid sequencing panel
Figure 4 Pipeline analysis for targeted NGS of multiple inherited cancer syndromes using the <t>TruSight</t> Cancer panel. In our analysis pipeline, .fastq files are used for alignment and variant calling in Isaac Enrichment, Burrows-Wheeler Aligner (BWA) Enrichment, and NextGENe software, and .vcf files are then imported to GeneticistAssistant for variant filtering. Supervised analysis of filtered variants will allow the identification of disease-associated variants and/or of pathogenic variants associated with cancer predisposing syndromes outside the clinical context (incidental finding), with both being supported (if needed) by visual inspection of .bam files in Golden Helix GenomeBrowse (GB). Variants called because <t>of</t> <t>sequencing</t> errors are discarded on visual inspection of .bam files in Golden Helix GB. 1000G, 1000 Genomes Project; ACMG, American College of Med- ical Genetics and Genomics; Alt.var.freq., percentage of reads with alter- native allele; CDS, coding sequence; EVS, Exome Variant Server; ExAC, Exome Aggregation Consortium; In-house freq., variant frequency among all of the samples in our in-house database; MAF, minor allele frequency.
Trusight Myeloid Sequencing Panel, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trusight/TruSight+Myeloid+Sequencing+Panel/pmc12914417-63-19-18
Average 96 stars, based on 1 article reviews
trusight myeloid sequencing panel - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

95
Illumina Inc trusight tumor 170 panel
Figure 4 Pipeline analysis for targeted NGS of multiple inherited cancer syndromes using the <t>TruSight</t> Cancer panel. In our analysis pipeline, .fastq files are used for alignment and variant calling in Isaac Enrichment, Burrows-Wheeler Aligner (BWA) Enrichment, and NextGENe software, and .vcf files are then imported to GeneticistAssistant for variant filtering. Supervised analysis of filtered variants will allow the identification of disease-associated variants and/or of pathogenic variants associated with cancer predisposing syndromes outside the clinical context (incidental finding), with both being supported (if needed) by visual inspection of .bam files in Golden Helix GenomeBrowse (GB). Variants called because <t>of</t> <t>sequencing</t> errors are discarded on visual inspection of .bam files in Golden Helix GB. 1000G, 1000 Genomes Project; ACMG, American College of Med- ical Genetics and Genomics; Alt.var.freq., percentage of reads with alter- native allele; CDS, coding sequence; EVS, Exome Variant Server; ExAC, Exome Aggregation Consortium; In-house freq., variant frequency among all of the samples in our in-house database; MAF, minor allele frequency.
Trusight Tumor 170 Panel, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trusight/TruSight+Tumor+170+Content+Set/pmc10605186-223-20-19
Average 95 stars, based on 1 article reviews
trusight tumor 170 panel - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

Image Search Results


( A ) Next-generation sequencing by using Illumina TSO500 identified EWSR1-CREM fusion in the tumor. Additional benign and uncertain mutations in ASXL1, PARP1, EPHAS, CCND3 were found. ( B ) Upon closer examination of the EWSR1-CREM fusion, we were able to determine ( C ) that this tumor originated from a fusion event involving exon 8 of the gene EWSR1 and exon 6 of the gene CREM.

Journal: Medicina

Article Title: Elucidating the Diagnostic Complexity of Round Cell Sarcoma with EWSR1-CREM Fusion: A Comprehensive Case Study

doi: 10.3390/medicina60040544

Figure Lengend Snippet: ( A ) Next-generation sequencing by using Illumina TSO500 identified EWSR1-CREM fusion in the tumor. Additional benign and uncertain mutations in ASXL1, PARP1, EPHAS, CCND3 were found. ( B ) Upon closer examination of the EWSR1-CREM fusion, we were able to determine ( C ) that this tumor originated from a fusion event involving exon 8 of the gene EWSR1 and exon 6 of the gene CREM.

Article Snippet: Therefore, we performed Next-generation sequencing by using Illumina TruSight™ Oncology 500, and the fusion gene EWSR1-CREM was detected in the specimen.

Techniques: Next-Generation Sequencing

Figure 4 Pipeline analysis for targeted NGS of multiple inherited cancer syndromes using the TruSight Cancer panel. In our analysis pipeline, .fastq files are used for alignment and variant calling in Isaac Enrichment, Burrows-Wheeler Aligner (BWA) Enrichment, and NextGENe software, and .vcf files are then imported to GeneticistAssistant for variant filtering. Supervised analysis of filtered variants will allow the identification of disease-associated variants and/or of pathogenic variants associated with cancer predisposing syndromes outside the clinical context (incidental finding), with both being supported (if needed) by visual inspection of .bam files in Golden Helix GenomeBrowse (GB). Variants called because of sequencing errors are discarded on visual inspection of .bam files in Golden Helix GB. 1000G, 1000 Genomes Project; ACMG, American College of Med- ical Genetics and Genomics; Alt.var.freq., percentage of reads with alter- native allele; CDS, coding sequence; EVS, Exome Variant Server; ExAC, Exome Aggregation Consortium; In-house freq., variant frequency among all of the samples in our in-house database; MAF, minor allele frequency.

Journal: The Journal of molecular diagnostics : JMD

Article Title: Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes.

doi: 10.1016/j.jmoldx.2017.05.001

Figure Lengend Snippet: Figure 4 Pipeline analysis for targeted NGS of multiple inherited cancer syndromes using the TruSight Cancer panel. In our analysis pipeline, .fastq files are used for alignment and variant calling in Isaac Enrichment, Burrows-Wheeler Aligner (BWA) Enrichment, and NextGENe software, and .vcf files are then imported to GeneticistAssistant for variant filtering. Supervised analysis of filtered variants will allow the identification of disease-associated variants and/or of pathogenic variants associated with cancer predisposing syndromes outside the clinical context (incidental finding), with both being supported (if needed) by visual inspection of .bam files in Golden Helix GenomeBrowse (GB). Variants called because of sequencing errors are discarded on visual inspection of .bam files in Golden Helix GB. 1000G, 1000 Genomes Project; ACMG, American College of Med- ical Genetics and Genomics; Alt.var.freq., percentage of reads with alter- native allele; CDS, coding sequence; EVS, Exome Variant Server; ExAC, Exome Aggregation Consortium; In-house freq., variant frequency among all of the samples in our in-house database; MAF, minor allele frequency.

Article Snippet: Library Preparation and Sequencing For library preparation, we followed the manufacturer’s instructions (TruSight Rapid Capture Kit; Illumina Inc., San Diego, CA).

Techniques: Variant Assay, Software, Sequencing